Latest News
Lupin's VISUfarma signs European licensing deal for presbyopia therapy YUVEZZI
20 August 2026 - Indian pharmaceutical companies Lupin Limited (BSE: 500257; NSE: LUPIN) said on Thursday it has agreed an exclusive licensing deal with commercial-stage ophthalmic pharmaceutical company Tenpoint Therapeutics Ltd., granting Lupin...
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
20 August 2026 - Pharmaceutical research services provider Charles River Laboratories International Inc (NYSE:CRL) and Medigen Vaccine Biologics Corp (MVC), a developer of vaccines for infectious diseases, announced on Thursday that they are collabor...
Annexin Pharmaceuticals receives proposed INN vanexin for ANXV
20 August 2026 - Clinical stage biotechnology company Annexin Pharmaceuticals AB (FN STO:ANNX) said on Thursday that the World Health Organization (WHO) has selected vanexin as the proposed International Nonproprietary Name (INN) for its drug candida...
Pillar Biosciences, LC-SCRUM-Asia and LSI Medience collaborate for liquid biopsy screening in lung cancer
20 August 2026 - US-based biotechnology company Pillar Biosciences Inc announced on Wednesday a collaboration with LC-SCRUM-Asia, a lung cancer screening project, and LSI Medience Corporation, a Japanese subsidiary of PHC Holdings Corporation, to sup...
Arcato reports positive Phase 1 trial results for ARC-001 Gel
20 August 2026 - Biotechnology company Arcato Laboratories Inc announced on Wednesday successful topline results from its first-in-human Phase 1 study of ARC-001 Gel in patients following third molar (wisdom tooth) extraction surgery.According to Arc...